Added phototherapy discontinuation and simplified output to the AAP 2022 bilirubin tool

Updated the PediTools AAP 2022 bilirubin management tool to:

  • provide clinical decision support for when phototherapy might be discontinued (2 mg/dL below the threshold at the time when phototherapy was initiated, or lower if rebound hyperbilirubinemia risk factors exist)
  • simplified and cleaned up the output by consolidating it into its own area, instead of split between the different threshold notifications